Today: 9 April 2026
Why Ondas Holdings (ONDS) stock is moving today: resale filing, insider sale plan and Jan. 16 investor day
6 January 2026
1 min read

Why Ondas Holdings (ONDS) stock is moving today: resale filing, insider sale plan and Jan. 16 investor day

New York, Jan 6, 2026, 09:59 EST — Regular session

  • ONDS shares were down about 1% in early trade after fresh SEC filings on potential stock sales
  • Prospectus supplement registers 2.39 million shares for resale by certain holders
  • Investors are also looking ahead to Ondas’ Jan. 16 investor day and 2026 outlook

Ondas Holdings Inc shares fell about 1% in early trade on Tuesday after the drone and private wireless equipment maker disclosed new filings that could add stock supply to the market. The shares were down about 1% at $12.40 at 9:44 a.m. ET, after closing at $12.53 on Monday, and traded between $12.00 and $12.49.

The filings land as investors brace for a company-hosted investor day on Jan. 16, when Ondas said it plans to detail its updated business plan and provide a 2026 financial outlook. The company said the presentation will address key assumptions behind its 2026 plan, investment priorities and capital requirements, with a question-and-answer session to follow. Ondas Holdings Inc.

In a prospectus supplement filed on Monday — an SEC document that can allow existing holders to sell registered shares — Ondas registered 2,389,203 shares for resale by stockholders tied to exchange agreements involving its Ondas Autonomous Systems unit, a filing showed. Ondas said it will not receive proceeds from any sales, and each seller agreed to a daily cap equal to 5% of the stock’s average 10-day trading volume. Privet Ventures LLC, an investment company owned by CEO Eric Brock, is listed among the selling stockholders; the filing said Ondas owns about 99% of Ondas Autonomous Systems on a fully diluted basis, meaning after assuming options and warrants are converted. Ondas Holdings Inc.

Separately, a Form 144 notice — a required filing that signals a proposed sale under Rule 144 — showed Ron Stern, listed on the form as a director, planned to sell up to 176,944 shares after exercising stock options on Jan. 5. The filing also listed common stock sales over the past three months, including 400,000 shares on Dec. 31 and 100,000 shares on Jan. 2. Ondas Holdings Inc.

Ondas, which sells autonomous drone, counter-drone and robotics systems through its OAS unit and private wireless broadband gear through Ondas Networks, has also been reshaping its corporate profile. It said on Jan. 2 it planned to change its name to Ondas Inc. and moved its corporate headquarters to West Palm Beach, Florida; “today, we operate as a scaled, global defense and security technology platform,” Brock said. Ondas Holdings Inc.

For traders, the setup is a tug-of-war between near-term selling pressure and the chance that management uses investor day to reset expectations with clearer targets for revenue growth, operating leverage and spending. The stock’s quick swings around the $12 level show how sensitive the name remains to flow-driven moves.

The risk for bulls is straightforward: registered resale stock and insider selling plans can weigh on shares if demand does not keep pace, especially if management’s 2026 outlook falls short of what the recent run-up implies. If the investor day highlights higher capital needs than investors expect, dilution worries could return.

Stock Market Today

  • AbbVie's Humira Launch on TrumpRx with 86% Discount Sparks Valuation Questions
    April 9, 2026, 9:02 AM EDT. AbbVie (NYSE:ABBV) has introduced Humira on the TrumpRx platform at an 86% discount under a White House pricing deal aiming to reduce patient costs and widen drug access. This marks a significant US pricing strategy shift post exclusivity for Humira, a key immunology therapy driving substantial revenue. The stock trades near $206.69, about 20% below analyst targets and 43.8% under fair value estimates. The deep discount could alter patient volume, payer ties, and pricing benchmarks in government-linked drug programs. AbbVie's revenue exposure of $61.2 billion and a high price-to-earnings ratio of 87.3 place focus on potential impacts to cash flow and dividends amid its debt load. Investors should monitor reactions from payers, competitors, and capital markets to this pricing shift that could redefine AbbVie's US market dynamics.

Latest article

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

When Will Gas Prices Fall? Iran Ceasefire May Not Bring Quick Relief as Oil Rebounds

9 April 2026
Brent crude rebounded 3% Thursday despite a U.S.-Iran ceasefire, with the Strait of Hormuz still nearly shut and only one oil-products tanker passing in 24 hours. U.S. gasoline averaged $4.166 a gallon on April 9, and AAA said prices could drop slowly. North Sea Forties crude hit a record $146.43 a barrel. The U.S. EIA expects Hormuz flows may take months to recover.
CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

CoreWeave Stock Climbs on $21 Billion Meta AI Cloud Deal, but Debt Risks Stay in Focus

9 April 2026
CoreWeave said Meta Platforms committed about $21 billion for AI cloud capacity through December 2032. Shares rose 4.3% to $88.90 in premarket trading after the announcement. The deal follows an $8.5 billion loan facility and a $1.25 billion senior notes offering. CoreWeave reported $5.13 billion in 2025 revenue and ended December with a $66.8 billion backlog.
NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

NVIDIA’s Rubin AI Chip Ramp Hits Fresh Snag as HBM4 Memory Crunch Clouds 2026

9 April 2026
TrendForce said April 8 that Nvidia’s Rubin AI chip shipments may be delayed by HBM4 memory qualification and cooling demands, shifting over 70% of 2026 high-end GPU volume to the current Blackwell line. Rubin’s projected share dropped to 22%. Samsung began shipping HBM4 to Nvidia in February, but SK Hynix and Micron face qualification delays. Broadcom signed a long-term deal to develop Google’s TPUs through 2031.
Gold.com stock steadies as Monex deal closes and gold prices hit a one-week high
Previous Story

Gold.com stock steadies as Monex deal closes and gold prices hit a one-week high

Bitcoin price today holds near $94,000; Strategy (MSTR) stock slips as Morgan Stanley files for crypto ETFs
Next Story

Bitcoin price today holds near $94,000; Strategy (MSTR) stock slips as Morgan Stanley files for crypto ETFs

Go toTop